FDA Approves Quadruplet Regimen for Adults With Newly Diagnosed Multiple Myeloma

WEDNESDAY, Feb. 4, 2026-- The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of adult patients with...